echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: A predictive model that predicts responsiveness to neoadjuvant therapy in patients with rectal cancer

    Br J Cancer: A predictive model that predicts responsiveness to neoadjuvant therapy in patients with rectal cancer

    • Last Update: 2022-05-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Rectal cancer is a common malignancy in the gastrointestinal tract, accounting for 3.


    Rectal cancer is a common malignancy in the gastrointestinal tract, accounting for 3.


    Tumor regression grade (TRG) and tumor downstaging are generally used for the treatment of neoadjuvant chemoradiotherapy and monitoring of prognostic parameters in clinical individuals


    In this study, the researchers aimed to develop and validate a multicenter predictive model that included a baseline


    The researchers collected baseline MRI and clinical characteristics of neoadjuvant treatment modalities in 674 patients from four central institutions


    The results showed that both non-imaging models were less predictive


    Both non-imaging models were less predictive



    Radiomics-based imaging models are more predictive than non-imaging models Radiomics- based imaging models are more predictive than non-imaging models MBR features seem to reflect the true state of LARC patients more accurately than other clinical parameters, And help to identify patients who can accept organ preservation treatment strategies


    Original source:

    Song, M.




    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.